Biotech News
Related news
ALGSAligos Therapeutics2026-10-05 20:05 EST
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
NAMSNewAmsterdam Pharma2026-07-01 12:00 EST
NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
CVRXCVRx2026-11-17 21:05 EST
CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference
ALGSAligos Therapeutics2026-09-02 12:00 EST
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
SGMTSagimet Biosciences2026-08-04 11:00 EST
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
CVRXCVRx2026-07-28 12:30 EST
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
SGMTSagimet Biosciences2026-10-29 11:00 EST
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MNKDMannKind2026-10-14 20:01 EST
MannKind to Participate in the Chardan Healthcare Conference
MLYSMineralys Therapeutics2026-10-02 20:30 EST
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
ALTAltimmune2026-09-03 12:00 EST
Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
Synlogic
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
Recent company news
SYBXSynlogic2026-07-29 11:00 EST
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
SYBXSynlogic2024-11-12 21:35 EST
Synlogic Reports Third Quarter 2024 Financial Results
SYBXSynlogic2024-08-08 11:00 EST
Synlogic Reports Second Quarter 2024 Financial Results
SYBXSynlogic2024-05-14 11:00 EST
Synlogic Reports First Quarter 2024 Financial Results
SYBXSynlogic2024-03-19 11:00 EST
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
Stock data
- Close
- 0.96 USD
- Market cap
- —
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
